| For: | Jia EZ, Yang ZJ, Chen SW, Qi GY, You CF, Ma JF, Zhang JX, Wang ZZ, Qian WC, Li XL, Wang HY, Ma WZ. Significant association of insulin and proinsulin with clustering of cardiovascular risk factors. World J Gastroenterol 2005; 11(1): 149-153 [PMID: 15609415 DOI: 10.3748/wjg.v11.i1.149] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i1/149.htm |
| Number | Citing Articles |
| 1 |
Andreas Pfützner, Thomas Schöndorf, Daniela Seidel, Karl Winkler, Stephan Matthaei, Andreas Hamann, Thomas Forst. Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride. Metabolism 2006; 55(1): 20 doi: 10.1016/j.metabol.2005.06.021
|
| 2 |
A. O. Shpakov. Mechanisms of action and therapeutic potential of proinsulin C-peptide. Journal of Evolutionary Biochemistry and Physiology 2017; 53(3): 180 doi: 10.1134/S0022093017030024
|
| 3 |
Maria E. Trujillo, Yue Han, Rebecca A. Baillie, Michael C. Weis, Douglas Chung, Sean Hayes, Paul E. Carrington, Michael Reed. In Silico Hypothesis Testing in Drug Discovery: Using Quantitative Systems Pharmacology Modeling to Evaluate the Therapeutic Value of Proinsulin Conversion to Insulin Therapy for Type 2 Diabetes Mellitus. Pharmaceutics 2025; 17(12): 1522 doi: 10.3390/pharmaceutics17121522
|
